IL163744A0 - Multi-substituted selective and rogenreceptor modulators and methods of use thereof - Google Patents

Multi-substituted selective and rogenreceptor modulators and methods of use thereof

Info

Publication number
IL163744A0
IL163744A0 IL16374403A IL16374403A IL163744A0 IL 163744 A0 IL163744 A0 IL 163744A0 IL 16374403 A IL16374403 A IL 16374403A IL 16374403 A IL16374403 A IL 16374403A IL 163744 A0 IL163744 A0 IL 163744A0
Authority
IL
Israel
Prior art keywords
rogenreceptor
modulators
methods
selective
substituted
Prior art date
Application number
IL16374403A
Other languages
English (en)
Original Assignee
Univ Tennessee Res Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/084,680 external-priority patent/US20030022868A1/en
Application filed by Univ Tennessee Res Foundation filed Critical Univ Tennessee Res Foundation
Publication of IL163744A0 publication Critical patent/IL163744A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL16374403A 2002-02-28 2003-02-24 Multi-substituted selective and rogenreceptor modulators and methods of use thereof IL163744A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/084,680 US20030022868A1 (en) 2001-06-25 2002-02-28 Selective androgen receptor modulators and methods of use thereof
US42338102P 2002-11-04 2002-11-04
PCT/US2003/003123 WO2003074449A2 (en) 2002-02-28 2003-02-24 Multi-substitued selective androgen receptor modulators and methods of use thereof

Publications (1)

Publication Number Publication Date
IL163744A0 true IL163744A0 (en) 2005-12-18

Family

ID=27791169

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16374403A IL163744A0 (en) 2002-02-28 2003-02-24 Multi-substituted selective and rogenreceptor modulators and methods of use thereof
IL163744A IL163744A (en) 2002-02-28 2004-08-25 Multi-substituted selective androgen receptor modulators and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL163744A IL163744A (en) 2002-02-28 2004-08-25 Multi-substituted selective androgen receptor modulators and uses thereof

Country Status (10)

Country Link
AU (1) AU2003216153B2 (zh)
BR (1) BR0308176A (zh)
CA (1) CA2477737C (zh)
EA (1) EA013818B1 (zh)
GE (1) GEP20074209B (zh)
HR (1) HRP20040830A2 (zh)
IL (2) IL163744A0 (zh)
MX (1) MXPA04009460A (zh)
TW (1) TWI338678B (zh)
WO (1) WO2003074449A2 (zh)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7759520B2 (en) 1996-11-27 2010-07-20 University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US20040260108A1 (en) * 2001-06-25 2004-12-23 Dalton James T. Metabolites of selective androgen receptor modulators and methods of use thereof
US7919647B2 (en) 2000-08-24 2011-04-05 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US8445534B2 (en) 2000-08-24 2013-05-21 University Of Tennessee Research Foundation Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
US7622503B2 (en) 2000-08-24 2009-11-24 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US7855229B2 (en) 2000-08-24 2010-12-21 University Of Tennessee Research Foundation Treating wasting disorders with selective androgen receptor modulators
US7645898B2 (en) 2000-08-24 2010-01-12 University Of Tennessee Research Foundation Selective androgen receptor modulators and method of use thereof
US8853266B2 (en) 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
CA2514024A1 (en) * 2003-01-22 2004-08-05 Gtx Inc. Treating androgen deficiency in female (adif)-associated conditions with sarms
DK1753417T3 (da) * 2004-06-07 2012-07-23 Univ Tennessee Res Foundation Selektiv androgenreceptormodulator og medicinske anvendelser deraf
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
PL1753417T3 (pl) * 2004-06-07 2012-09-28 Univ Tennessee Res Found Selektywny modulator receptora androgenowego i jego zastosowania medyczne
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
EP2425715B1 (en) * 2005-08-31 2014-03-05 University of Tennessee Research Foundation Treating symptoms of renal disease with selective androgen receptor modulators (SARM)
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
KR20120115380A (ko) 2010-01-11 2012-10-17 지티엑스, 인코포레이티드 마이봄선 기능 장애의 치료 방법
LT2872482T (lt) 2012-07-13 2020-12-28 Oncternal Therapeutics, Inc. Krūties vėžių gydymo būdas selektyviu androgeno receptoriaus moduliatoriumi
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8617653D0 (en) * 1986-07-18 1986-08-28 Ici Plc Amide derivatives
US6071957A (en) * 1996-11-27 2000-06-06 The University Of Tennessee Research Corporation Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
WO1998053826A1 (en) * 1997-05-30 1998-12-03 The University Of Tennessee Research Corporation Non-steroidal agonist compounds and their use in male hormone therapy
US6019957A (en) * 1997-06-04 2000-02-01 The University Of Tennessee Research Corporation Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
AU8523001A (en) * 2000-08-24 2002-03-04 Gtx Inc Selective androgen receptor modulators and methods of use thereof
BR0215115A (pt) * 2001-12-06 2005-04-19 Gtx Inc Tratamento de perda muscular com moduladores de receptores de androgênio seletivos

Also Published As

Publication number Publication date
HRP20040830A2 (en) 2005-06-30
AU2003216153A1 (en) 2003-09-16
GEP20074209B (en) 2007-10-10
EA013818B1 (ru) 2010-08-30
IL163744A (en) 2013-03-24
WO2003074449A3 (en) 2003-12-18
TW200307661A (en) 2003-12-16
CA2477737A1 (en) 2003-09-12
EA200401122A1 (ru) 2005-06-30
MXPA04009460A (es) 2006-04-27
AU2003216153B2 (en) 2008-01-24
WO2003074449A2 (en) 2003-09-12
TWI338678B (en) 2011-03-11
BR0308176A (pt) 2005-01-04
CA2477737C (en) 2012-08-07

Similar Documents

Publication Publication Date Title
IL163744A0 (en) Multi-substituted selective and rogenreceptor modulators and methods of use thereof
IL165792A0 (en) N-bridged selective androgen receptor modulators and methods of use thereof
HK1079789A1 (zh) 血管靜態毒性試劑及其使用方法
AU2003259717A8 (en) Modulators of rabggt and methods of use thereof
AU2003278832A8 (en) Optical biosensors and methods of use thereof
EP1663204A4 (en) C-KIT MODULATORS AND METHODS OF USE
EP1610774A4 (en) TIE-2 MODULATORS AND METHODS OF USE
EP1465615A4 (en) TRICYCLIC BISENONE DERIVATIVES AND METHODS OF USE
EP1562594A4 (en) SELECTIVE ANDROGEN RECEPTOR MODULATORS WITH METHYLENE BRIDGES AND METHOD OF USE THEREOF
AU2003231048A8 (en) Transposon system and methods of use
EP1501514A4 (en) PROTEIN-KINASE MODULATORS AND METHODS OF USE
IL172986A0 (en) Hairpin -labeled probes and methods of use
EP1521747A4 (en) RECEPTOR TYPE KINASE MODULATORS AND METHODS OF USE
EP1611123A4 (en) TIE-2 MODULATORS AND METHOD OF USE
AU2003288902A1 (en) Microcapsules and methods of use
HK1067977A1 (en) Illuminated toothbrush and method of use
EP1562906A4 (en) SELECTIVE ANDROGEN RECEPTOR HETEROCYCLIC MODULATORS AND METHODS OF USE THEREOF
IL154425A0 (en) Selective androgen receptor modulators and methods of use thereof
AU2003207698A8 (en) Needle-suture combinations and methods of use
AU2003303128A8 (en) Inhibitors and methods of use thereof
PL376532A1 (pl) Pochodne podstawionych benzyloamin oraz sposoby wykorzystania
EP1476150A4 (en) CARBOXY FULLERES AND USE METHOD THEREFOR
AU2003243714A8 (en) Etoposide analogs and methods of use thereof
IL163742A0 (en) Irreversible selective androgen receptor modulators and methods of use thereof
EP1608373A4 (en) TIE-2 MODULATORS AND USE METHOD